Delivery Order SPE2DB22D3004-SPE2DB24FRB32
Award Date
7/15/24
Potential Completion Date
7/16/24
Potential Value
$4.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $1,889.10 to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the provision of GARDASIL 9 SYRINGE 0.5ML, a pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of...
The U.S. Defense Logistics Agency (DLA) awarded a $8,720.22 firm-fixed price delivery order to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, for the supply of GARDASIL 9 SYRINGE 0.5ML vaccines. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of...
The U.S. Defense Logistics Agency (DLA) awarded a $9,366.31 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of GARDASIL 9 syringes. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded by DLA to Amerisourcebergen Drug Corp to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA Troop Support Medical...
The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide GARDASIL 9 SYRINGE 0.5ML pharmaceutical products. The contract, valued at $20,560.75, has a completion date of January 31, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor and is not operating under any set-aside designation....
The U.S. government agency Medical Supply Chain, part of the Defense Department, awarded a $12,934.24 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the provision of GARDASIL 9 SYRINGE 0.5ML, a pharmaceutical product, with a performance period through May 24, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the Defense Logistics Agency...
The U.S. Department of Defense's Medical Supply Chain (VPDLATSMED-A) awarded a $3,233.58 delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division to provide GARDASIL 9 SYRINGE 0.5ML medical supplies. This contract has an ultimate completion date of May 13, 2024 and does not have a set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA)...
The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide GARDASIL 9 SYRINGE 10S, a pharmaceutical product. The $28,867.54 contract has an ultimate completion date of April 5, 2024. AmerisourceBergen Drug Corp is the prime contractor and the parent company is Cencora, Inc. which does business as AmerisourceBergen. This...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $6,528.44 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of GARDASIL 9 vaccine syringes. This delivery order is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 awarded to AmerisourceBergen Drug Corp as the sole prime contractor, which serves as the primary vehicle for the company to provide a range of pharmaceutical...
This is a $10,784.33 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Medical Supply Chain to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract is for the delivery of GARDASIL 9 SYRINGE 0.5ML and has an ultimate completion date of April 29, 2024. Amerisourcebergen, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide GARDASIL 9 SYRINGE 0.5ML. This $11,765.66 delivery order contract has an ultimate completion date of April 3, 2024. AmerisourceBergen Drug Corp serves as the prime contractor on this contract, which is not set aside for any specific business type. This delivery order is part of a larger indefinite delivery contract (IDC)...